Autoimmune

Bi

India Approves Autoimmune Drug Trial

An Ruwaito ta hanyar AI An Binciki Gaskiya

India's CDSCO has approved a new trial for an autoimmune drug by Mankind Pharma, following successful multicentric trials for other medical devices. This development addresses rising needs for treatments amid increasing lifestyle disease deaths. The trial focuses on broad therapeutic applications for autoimmune conditions.

Wannan gidan yanar gizon yana amfani da kukis

Muna amfani da kukis don bincike don inganta shafinmu. Karanta manufofin sirri namu manufofin sirri don ƙarin bayani.
Ki